RHY 4.76% 6.0¢ rhythm biosciences limited

Slow and steady... good to see another Aussie pathology "giant"...

  1. 457 Posts.
    lightbulb Created with Sketch. 124
    Slow and steady... good to see another Aussie pathology "giant" (Helius ($1.4B) working RHY, alongside Sonic ($9B) on ColoStat.
    Key milestones are TGA approval and revenue this CY all of which seems achievable considering their reliability in hitting all key milestones to date.
    GLTAH
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.